{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:50:16Z","timestamp":1790268616652,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejmech.2024.117018","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T04:39:13Z","timestamp":1730349553000},"page":"117018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Design, synthesis, and in vitro and in vivo biological evaluation of dihydroartemisinin derivatives as potent anti-cancer agents with ferroptosis-inducing and apoptosis-activating properties"],"prefix":"10.1016","volume":"281","author":[{"given":"Qian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Sheng","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Zhe","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Kun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4986-8794","authenticated-orcid":false,"given":"Zhe-Shan","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117018_bib1","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(10)60942-7","article-title":"Moving cancer up the global health agenda","volume":"375","author":"The","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.117018_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/cells8020170","article-title":"Leukocyte\u2013cancer cell fusion\u2014genesis of a deadly journey","volume":"8","author":"Laberge","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2024.117018_bib3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3389\/fphar.2018.01308","article-title":"The role of natural products in targeting cardiovascular diseases via Nrf2 pathway: novel molecular mechanisms and therapeutic approaches","volume":"9","author":"Ooi","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117018_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3835(06)80014-5","article-title":"Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat","volume":"98","author":"Moore","year":"1995","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2024.117018_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11010-013-1639-1","article-title":"Small interfering RNA targeting Rac1 sensitizes colon cancer to dihydroartemisinin-induced cell cycle arrest and inhibited cell migration by suppressing NFkappaB activity","volume":"379","author":"Han","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2024.117018_bib6","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s10495-015-1132-2","article-title":"Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells","volume":"20","author":"Qin","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2024.117018_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.lfs.2017.11.008","article-title":"Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells","volume":"192","author":"Im","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.117018_bib8","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1002\/cam4.1827","article-title":"Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway","volume":"7","author":"Liu","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejmech.2024.117018_bib9","doi-asserted-by":"crossref","first-page":"87271","DOI":"10.18632\/oncotarget.13536","article-title":"Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-kappaB\/GLUT1 axis","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.117018_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1043-6618(03)00107-5","article-title":"Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro","volume":"48","author":"Chen","year":"2003","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.117018_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jdermsci.2020.08.001","article-title":"Dihydroartemisinin inhibits melanoma by regulating CTL\/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner","volume":"99","author":"Yu","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejmech.2024.117018_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellimm.2011.06.008","article-title":"Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo","volume":"271","author":"Noori","year":"2011","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ejmech.2024.117018_bib13","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/abbs\/gmy125","article-title":"Artemisinin derivatives inhibit epithelial ovarian cancer cells via autophagy-mediated cell cycle arrest","volume":"50","author":"Li","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ejmech.2024.117018_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-9966-33-8","article-title":"The activation of c-Jun NH(2)-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells","volume":"33","author":"Jia","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.117018_bib15","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s10637-010-9481-8","article-title":"The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells","volume":"29","author":"Lu","year":"2011","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejmech.2024.117018_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3389\/fonc.2020.00965","article-title":"Heme-dependent ER stress apoptosis: a mechanism for the selective toxicity of the dihydroartemisinin, NSC735847, in colorectal cancer cells","volume":"10","author":"Elhassanny","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2024.117018_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/molecules22020323","article-title":"Design of drug delivery systems containing artemisinin and its derivatives","volume":"22","author":"Aderibigbe","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117018_bib18","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.7689747","article-title":"An unnatural biopolymer","volume":"261","author":"Cho","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.117018_bib19","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/jm501371s","article-title":"Organic carbamates in drug design and medicinal chemistry","volume":"58","author":"Ghosh","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib20","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.2174\/1871520622666220217161346","article-title":"Recent advances in synthesis and anticancer potential of triazole-containing scaffolds","volume":"22","author":"Bhagat","year":"2022","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111700","article-title":"1,2,3-Triazole-containing hybrids as potential anticancer agents: current developments, action mechanisms and structure-activity relationships","volume":"183","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/acs.jnatprod.1c00377","article-title":"Synthesis and evaluation of bakuchiol derivatives as potent anti-inflammatory agents","volume":"85","author":"Ma","year":"2022","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.117018_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.apsb.2019.09.002","article-title":"Synthesis, and biological evaluation of novel lappaconitine derivatives as potential anti-inflammatory agents","volume":"10","author":"Pang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2024.117018_bib24","first-page":"144","article-title":"Design, synthesis, and anticancer activity evaluation of hybrids of azoles and barbituric acids","volume":"20","author":"Liu","year":"2021","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.ejmech.2024.117018_bib25","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jgr.2022.03.001","article-title":"Ginsengenin derivatives synthesized from 20(R)-panaxotriol: synthesis, characterization, and antitumor activity targeting HIF-1 pathway","volume":"46","author":"Guo","year":"2022","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.ejmech.2024.117018_bib26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ejmech.2018.08.036","article-title":"Novel antitumor compound optimized from natural saponin Albiziabioside A induced caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway","volume":"157","author":"Wei","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib27","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1016\/j.arabjc.2016.10.009","article-title":"Comprehensive review on current developments of quinoline-based anticancer agents","volume":"12","author":"Jain","year":"2019","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib28","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1021\/jm0510676","article-title":"Synthesis and biological activity of 7-phenyl-6,9-dihydro-3H-pyrrolo[3,2-f]quinolin-9-ones: a new class of antimitotic agents devoid of aromatase activity","volume":"49","author":"Gasparotto","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s11094-021-02529-3","article-title":"Synthesis, evaluation of anti- activity and molecular docking of dihydroartemisinin derivatives","volume":"55","author":"Deng","year":"2022","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2024.117018_bib30","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.pharep.2019.07.011","article-title":"Coumarin and 3,4-dihydroquinolinone derivatives: synthesis, antidepressant activity, and molecular docking studies","volume":"71","author":"Wang","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2024.117018_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113474","article-title":"Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1\u03b1 pathway","volume":"220","author":"Shang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib32","first-page":"1","article-title":"Synthesis and use of pseudopeptides derived from 1,2,4-oxadiazole-, 1,3,4-oxadiazole-, and 1,2,4-Triazole-based dipeptidomimetics","volume":"23","author":"Luthman","year":"1999","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.ejmech.2024.117018_bib33","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1021\/jm990197+","article-title":"Design, synthesis, and evaluation of Phe-Gly mimetics: heterocyclic building blocks for pseudopeptides","volume":"42","author":"Borg","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib34","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1021\/jo00115a029","article-title":"Synthesis of 1,2,4-oxadiazole-, 1,3,4-oxadiazole-, and 1,2,4-triazole-derived dipeptidomimetics, the J","volume":"60","author":"Borg","year":"2002","journal-title":"Org. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib35","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1021\/acs.jmedchem.2c00664","article-title":"Seco-lupane triterpene derivatives induce ferroptosis through GPX4\/ACSL4 Axis and target cyclin D1 to block the cell cycle","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib36","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1021\/acs.jnatprod.1c01236","article-title":"Design and synthesis of novel celastrol derivatives as potential anticancer agents against gastric cancer cells","volume":"85","author":"Lei","year":"2022","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.117018_bib37","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1007\/s00044-021-02803-9","article-title":"Synthesis and evaluation of mycophenolic acid derivatives as potential anti- agents","volume":"30","author":"Shang","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.117018_bib38","first-page":"2055","article-title":"Synthesis, characterization and in vitro anti-proliferative effects of pentacyclic triterpenoids","volume":"30","author":"Wang","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.117018_bib39","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1590\/0001-3765201820170830","article-title":"Current antimalarial therapies and advances in the development of semi-synthetic artemisinin derivatives","volume":"90","author":"Pinheiro","year":"2018","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.ejmech.2024.117018_bib40","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1517\/17460441.2013.798296","article-title":"Advances in the development of hybrid anticancer drugs","volume":"8","author":"Fortin","year":"2013","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.117018_bib41","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/molecules21101331","article-title":"Artemisinin and its derivatives as a repurposing anticancer agent: what else do we need to do?","volume":"21","author":"Li","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117018_bib42","doi-asserted-by":"crossref","first-page":"9372","DOI":"10.1074\/jbc.M610375200","article-title":"Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds","volume":"282","author":"Mercer","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib43","doi-asserted-by":"crossref","first-page":"12890","DOI":"10.1002\/slct.202102459","article-title":"Synthesis of 1\u2010(3\u2010(1\u2010substituted\u20101,2,3\u2010triazol\u20104\u2010yl)\u20101,2,4\u2010triazol\u20105\u2010yl)\u2010tetrazoles by Sequential Assembly of Azole Fragments","volume":"6","author":"Zviagin","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2024.117018_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2019.04.005","article-title":"Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: a novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway","volume":"173","author":"Shen","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1515\/hc.2011.002","article-title":"Synthesis of N 1-alkyl-1,4-diazepin-5-ones via Schmidt ring expansion chemistry","volume":"17","author":"Frick","year":"2011","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.ejmech.2024.117018_bib46","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.tetlet.2017.08.020","article-title":"Room-temperature synthesis of pharmaceutically important carboxylic acids bearing the 1,2,4-oxadiazole moiety","volume":"58","author":"Tarasenko","year":"2017","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2024.117018_bib47","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1002\/ejoc.201300770","article-title":"Solution phase and nanoparticular biosynthetically inspired interconnections in the canthin-6-one \u03b2-carboline series and study of phenotypic properties onC. Elegans","volume":"2013","author":"Cebri\u00e1n-Torrej\u00f3n","year":"2013","journal-title":"Eur J Org Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib48","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.3390\/polym14214716","article-title":"Biomimetic mineralized hydrophilic polyurethane primers for inducing dentin tubule fillings","volume":"14","author":"Tian","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.ejmech.2024.117018_bib49","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1470-2045(19)30145-7","article-title":"Dose recommendations for anticancer drugs in patients with renal or hepatic impairment","volume":"20","author":"Krens","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmech.2024.117018_bib50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.117018_bib51","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.bbagen.2017.05.019","article-title":"Ferroptosis: role of lipid peroxidation, iron and ferritinophagy","volume":"1861","author":"Latunde-Dada","year":"2017","journal-title":"BBA-Gen Subj."},{"key":"10.1016\/j.ejmech.2024.117018_bib52","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","article-title":"Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis","volume":"27","author":"Chen","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2024.117018_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175028","article-title":"Dihydroartemisinin inhibits the growth of pancreatic cells by inducing ferroptosis and activating antitumor immunity","volume":"926","author":"Zhang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117018_bib54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.117018_bib55","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1021\/acs.jmedchem.1c00569","article-title":"Discovery of a potent glutathione peroxidase 4 inhibitor as a selective ferroptosis inducer","volume":"64","author":"Xu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3892\/ijo.2023.5492","article-title":"Dual targets of lethal apoptosis and protective autophagy in liver cancer with periplocymarin elicit a limited therapeutic effect","volume":"62","author":"Hao","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2024.117018_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112386","article-title":"Novel NO-releasing scopoletin derivatives induce cell death via mitochondrial apoptosis pathway and cell cycle arrest","volume":"200","author":"Shi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib58","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1021\/jm2013425","article-title":"Synthesis and evaluation of the cytotoxicities of tetraindoles: observation that the 5-hydroxy tetraindole (SK228) induces G(2) arrest and apoptosis in human breast cancer cells","volume":"55","author":"Li","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib59","doi-asserted-by":"crossref","first-page":"11935","DOI":"10.1021\/acs.jafc.8b04442","article-title":"Induction of apoptosis and cell-cycle arrest in human colon-cancer cells by whole-grain alkylresorcinols via activation of the p53 pathway","volume":"66","author":"Fu","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2024.117018_bib60","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death Differ."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T08:57:05Z","timestamp":1734253025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424009000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":60,"alternative-id":["S0223523424009000"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117018","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and in vitro and in vivo biological evaluation of dihydroartemisinin derivatives as potent anti-cancer agents with ferroptosis-inducing and apoptosis-activating properties","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117018"}}